Akèy › Fibroz sistik › Kansas
Etid klinik pou Fibroz sistik nan Kansas
15 etid pou Fibroz sistik ap chèche patisipan nan sit nan Kansas.
Vil nan Kansas
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
- Johnson County Clin-Trials (JCCT), Lenexa
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Oct 1, 2026 · NCT07559175Phase 2 Study to Assess the Safety and Efficacy of ANG003
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07450547Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
- Altasciences - Kansas City, Overland Park
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Sep 21, 2026 · NCT07283770Sinus Disease in Young Children With Cystic Fibrosis
- University of Kansas Medical Center, Kansas City
Ap rekriteEtid obsèvasyon
Laj 2 a 8 · Tout sèks · Mizajou Sep 10, 2026 · NCT06191640Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
- University of Kansas Medical Center, Kansas City
Ap rekriteEtid obsèvasyon
Jiska laj 10 · Tout sèks · Mizajou Jul 8, 2026 · NCT04509050Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 4
Laj 6 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT055482834D-710 in Adult Patients With Cystic Fibrosis
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT05248230Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
- University of Kansas Medical Center, Kansas City
Ap rekriteEtid obsèvasyon
Laj 18 a 65 · Tout sèks · Mizajou Jul 1, 2026 · NCT06985225Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 1Volontè an sante akeyi
Laj 3 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT04624490Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT04530383Health Outcomes of Parents With Cystic Fibrosis-Aim 2
- University of Kansas Medical Center, Kansas City
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT06296394Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
- Kansas University Medical Center, Kansas City
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Nov 3, 2025 · NCT06683092A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- University of Kansas Medical Center, Kansas City
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Oct 1, 2025 · NCT06504589Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou May 2, 2025 · NCT06364176A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Nov 25, 2024 · NCT06526923Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.